Academic Health Center
Stay Connected
research-and-clinical-trials

Research snapshot: E-cigarettes may result in lower consumed toxicants for users, says new UMN research

E-cigarettes are a quickly growing market, and potentially for good reason. New research out of the Masonic Cancer Center, University of Minnesota shows the metabolized levels of disease-causing compounds are significantly lower in e-cigarettes than traditional cigarettes.

Read more
research-and-clinical-trials

U of M research finds kava plant may prevent cigarette smoke-induced lung cancer

New research from the University of Minnesota College of Pharmacy and Masonic Cancer Center has found that consumption of the root of Piper methysticum, or kava, a plant native to the South Pacific Islands, may prevent the development of tobacco smoke-induced lung cancer.

Read more
expert-perspectives

Cigarette turns 100: What we know now versus (cough!) then

The year is 1913. People are still shuddering at the thought of the Titanic and World War I is looming in the near future. Women aren’t allowed in voting booths and travelling daily by automobile seems like a foreign concept.

Unknown to anyone at the time, one of the biggest plagues on modern human health was about to begin its reign in society: the cigarette.

In October 1913, Camel cigarettes began rolling off the line at a pace of about 7 or 8 per second. Around 1 million were sold that year. From there, sales took off with twenty-one billion being sold in 1919. And until 1981, those numbers only grew.

Read more